LC-MS/MS screen for xenobiotics and metabolites

Methods in Molecular Biology

Volumn 902, Issue , 2012, Pages 129-138

  Sauvage, François Ludovic ^a   Marquet, Pierre ^a  

^a LIMOGES UNIVERSITY HOSPITAL   (France)

Author keywords

Forensic and clinical toxicology; General unknown screening; Linear ion trap; Liquid chromatography; Tandem mass spectrometry

Indexed keywords

XENOBIOTIC AGENT;

ARTICLE; BLOOD; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; METABOLISM; SOLID PHASE EXTRACTION; TANDEM MASS SPECTROMETRY; URINE;

CHROMATOGRAPHY, HIGH PRESSURE LIQUID; HUMANS; SOLID PHASE EXTRACTION; TANDEM MASS SPECTROMETRY; XENOBIOTICS;

EID: 84865347554     PISSN: 10643745     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-61779-934-1_11     Document Type: Article

References (15)

1. Saint-Marcoux F, Sauvage FL, Marquet P (2007) Current role of LC-MS in therapeutic drug monitoring. Anal Bioanal Chem 388:1327-1349
2. Marquet P (2002) Is LC-MS suitable for a comprehensive screening of drugs and poisons in clinical toxicology? Ther Drug Monit 24:125-133
3. Marquet P (2002) Progress of liquid chromatography-mass spectrometry in clinical and forensic toxicology. Ther Drug Monit 24:255-276
4. Maurer HH (2005) Multi-analyte procedures for screening for and quanti fi cation of drugs in blood, plasma; or serum by liquid chromatography-single stage or tandem mass spectrometry (LC-MS or LC-MS/MS) relevant to clinical and forensic toxicology. Clin Biochem 38:310-318
5. Maurer HH (2007) Current role of liquid chromatography-mass spectrometry in clinical and forensic toxicology. Anal Bioanal Chem 388:1315-1325
6. Maurer HH (2010) Perspectives of liquid chromatography coupled to low-and high resolution mass spectrometry for screening, identi fi cation, and quanti fi cation of drugs in clinical and forensic toxicology. Ther Drug Monit 32:324-327
7. Gergov M, Ojanperä I, Vuori E (2003) Simultaneous screening for 238 drugs by liquid chromatography-ion spray tandem mass spectrometry with multiple-reaction monitoring. J Chromatogr B Analyt Technol Biomed Life Sci 795:41-53
8. Sauvage FL, Gaulier JM, Lachâtre G, Marquet P (2008) Pitfalls and prevention strategies for liquid chromatography-tandem mass spectrometry in the selected-reaction monitoring mode for drug analysis. Clin Chem 54:1519-1527
9. Peters FT, Drummer OH, Musshoff O (2007) Validation of new methods. Forensic Sci Int 165:216-224
10. Hager JW, Le Blanc JC (2003) High performance liquid chromatography- tandem mass spectrometry with a new quadrupole/linear ion trap instrument. J Chromatogr A 1020:3-9
11. Sauvage FL, Saint-Marcoux F, Duretz B, Deporte D, Lachâtre G, Marquet P (2006) Screening of drugs and toxic compounds with liquid chromatography-linear ion trap tandem mass spectrometry. Clin Chem 52:1732-1742
12. Picard N, Dridi D, Sauvage FL, Boughattas NA, Marquet P (2009) General unknown screening procedure for the characterization of human drug metabolites. Application to loratadine phase I metabolism. J Sep Sci 32:2209-2217
13. Sauvage FL, Picard N, Saint-Marcoux F, Gaulier JM, Lachâtre G, Marquet P (2009) General unknown screening procedure for the characterization of human drug metabolites in forensic toxicology. Applications and constraints. J Sep Sci 32:3074-3083
14. Mueller CA, Weinmann W, Dresen S, Schreiber A, Gergov M (2005) Development of a multitarget screening analysis for 301 drugs using a QTrap liquid chromatography/tandem mass spectrometry system and automated library searching. Rapid Commun Mass Spectrom 19:1332-1338
15. Dresen S, Ferreiros N, Gnann H, Zimmermann R, Weinmann W (2010) Detection and identi fi cation of 700 drugs by multi-target screening with a 3200QTRAP LC-MS/MS system and library searching. Anal Bioanal Chem 396:2425-2434